HCM
ANIP icon

Highbridge Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Highbridge Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,800
Closed -$291K – 1420
2016
Q4 		$291K Sell
4,800
-6,200
-56% -$379K 0.01% 989
2016
Q3 		$730K Buy
11,000
+3,400
+45% +$213K 0.01% 653
2016
Q2 		$424K Sell
7,600
-1,600
-17% -$77.8K 0.01% 910
2016
Q1 		$310K Buy
+9,200
New +$312K 0.01% 1168
2015
Q3 		– Sell
-11,500
Closed -$714K – 1507
2015
Q2 		$714K Sell
11,500
-900
-7% -$53.6K 0.01% 838
2015
Q1 		$775K Buy
+12,400
New +$754K 0.01% 829

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return